bioserve
Currently not logged in:

BioServe Leadership

Ramakrishna V. Modali

President

Ramakrishna Modali is the Founder and President of BioServe Biotechnologies. Since BioServe's inception in 1989, Modali has striven to develop and provide advanced molecular biology services to pharmaceutical, academic and government institutions. With 30 years of experience in molecular biology, Modali continues to guide BioServe's successful growth, international expansion and apply cutting-edge science to overcome customers' genomics research challenges.

Prior to founding BioServe, Modali worked as a molecular biologist at the National Institutes of Health and National Cancer Institute. He has over 32 peer reviewed research publications.

Teresa A. Lehman, Ph.D.

Chief Technical Officer

Dr. Lehman has served as BioServe's Chief Technical Officer since 1993. She is responsible for development and maintenance of all standard operating procedures (SOPs) for all research work, as well as quality control across all products and services.

Prior to BioServe Lehman worked as a post-doctoral fellow at the National Cancer Institute and National Institutes of Health. At these institutions she helped develop PCR and sequencing techniques to investigate point mutations in the p53 tumor suppressor gene and the ras protooncogene in a variety of human samples. Lehman received her Ph.D. from The Ohio State University in the Department of Physiological Chemistry.

Mike Seddon

Laboratory Director

Mike Seddon has been with BioServe since 1992 and is responsible for the company's laboratory operations. In this capacity, he oversees the implementation of SOPs, equipment maintenance, and scheduling of the projects. Seddon also was responsible for converting a large number of BioServe's extraction and genotyping processes to high throughput formats including DNA extractions, TaqMan analysis, PCR-RFLP analysis, and DNA sequencing. Prior to joining BioServe, Seddon worked for 12 years at National Institutes of Health in the Laboratory of Human Carcinogenesis. During this time he has gained experience in tissue culture and molecular biology techniques. Seddon has a B.S. from The University of Maryland, and 24 years experience in molecular biology, tissue culture techniques, and protein biochemistry.

Eric Langlois

Vice President of Business Development

Eric is directly responsible for growing BioServe's business relationships and sales pipeline as well as managing its sales personnel. During Eric's time with BioServe he has lead the company to consecutive record breaking revenue years. He has accomplished this by managing the company's most lucrative accounts and by closing many of the top deals including the largest in the 18 year history of BioServe. Eric has also been instrumental in signing two current Co-Marketing deals as well as signing and managing several distribution agreements. Prior to joining BioServe, Eric was Northeast Territory Sales Manager for SeqWright, Inc. where he successfully established increased sales and brand recognition throughout the Northeast territory and beyond. Part of Eric's role with SeqWright involved maintaining and increasing the Global Preferred Vendor status to Merck and all subsidiaries. Prior to SeqWright Eric was Northeast Regional Sales Manager for Genomics Collaborative, a wholly owned subsidiary of SeraCare Life Sciences, Inc. He also began his career as a Laboratory Research Associate with Genomics Collaborative in 1999.

Eric Langlois received his BS in Biotechnology with a concentration in Biochemistry from Worcester Polytechnic Institute.